Temperature sensitive mutations in host cell factor 1 (HCF-1) arrest cells in the middle of the G1 phase of the cycle. We have shown that the highly conserved C-terminal WYF domain of HCF-1 protein interacts with the MYND domain of the PDCD2 protein. This interaction is conserved between human HCF-1 and HCF-2 and the C. elegans HCF. Overexpression of PDCD2, which interacts with the N-CoR/mSin3A corepressor complexes, suppresses cotransfected HCF-1 complementation of a temperature lesion in the endogenous HCF-1 protein. Overexpression of domains of either PDCD2 or HCF-1, which should interfere with interactions between these two proteins, enhances the complementation.
Introduction
Host cell factor 1 (HCF-1) was originally cloned as a component of the C1 complex, which is formed by the viral protein VP16, when Herpes simplex virus 1 (HSV-1) infects a cell (Wilson et al., 1993b; Kristie and Sharp, 1993; Kristie et al., 1995) . The C1 complex consists of two cellular factors, HCF-1 and Oct-1, in addition to VP16, and directs transcription of the immediate early genes of the virus (reviewed in Wilson et al., 1993a and Herr, 1998) . Oct-1 binds DNA specifically, the octamer site, and directs transcription of a diverse array of cellular genes (reviewed in Herr and Cleary, 1995; Ryan and Rosenfeld, 1997; Roeder, 1998; Schonemann et al., 1998) . HCF-1 is a 2035 amino acid protein that undergoes autoproteolysis at several sites in a region of repetitive segments resulting in separate amino-terminal and carboxy-terminal polypeptides that remain associated (Wilson et al., 1995b; Vogel and Kristie, 2000a) . In trigeminal ganglia cells, the entire HCF-1 protein (Kristie et al., 1999) and in resting Go cells in culture, portions of the Nterminus of HCF-1 may reside in the cytoplasm (Scarr et al., 2000) , but otherwise the protein is nuclear. The cellular functions of HCF-1 have not been elucidated. HCF-1 is ubiquitously expressed, does not bind DNA, but interacts with a number of DNA binding proteins such as GABP, SP1, and leucine zipper proteins (Lu et al., 1997; Vogel and Kristie, 2000b) . The C1 complex specifically binds the consensus TAATGARAT (R=purine) element in the immediate early promoters, and some have proposed that VP16 targets HCF-1 to detect the proliferative state of the cell because HCF-1 is most highly expressed in cycling cells Kristie and Sharp, 1990; Misra et al., 1996; Walker et al., 1994; Wilson et al., 1995a) .
Many recent studies of HCF-1 function in mammalian cells have focused on the role of the aminoterminal kelch domain, named for the D. melanogaster protein, kelch, in which a similar structural motif was first identified (Adams et al., 2000; Bork and Doolittle, 1994) . This region interacts with at least two cellular leucine zipper proteins, Luman and Zhangfei, and is the site of VP16 binding to HCF-1 in the C1 complex (Freiman and Lu and Misra, 2000; Lu et al., 1998; Wilson et al., 1997) . A mutation resulting in a single amino acid change in the kelch domain of HCF-1 causes a temperature-sensitive cell cycle arrest in BHK cells, indicating that wild type HCF-1 function is required for cell cycle progression in these cells . Mutations in HCF-1, which are defective for binding VP16, are also defective for complementation of the temperature-sensitive arrest but the same correlation is not observed for binding to Luman (Mahajan and Wilson, 2000) .
The functions of the carboxy-terminus of HCF-1 are poorly characterized, apart from its association with the N-terminal domain. The carboxy-terminus of HCF-1 contains a nuclear localization signal, and is required not only for the localization of HCF-1, but also for the nuclear import of VP16 (La Boissiere et al., 1999) . The only cellular protein known to interact with the carboxy-terminus of HCF-1 is protein phosphatase 1 (PP1), for which HCF-1 may function as a regulatory subunit (Ajuh et al., 2000) . The carboxy-terminus of HCF-1 contains the most highly conserved region of the protein, the WYF domain. This domain contains a stretch of 25 amino acids that are 100% identical between human HCF-1 and C. elegans HCF. We have used a yeast two-hybrid screen to identify a protein that specifically associates with the WYF domain of HCF-1, PDCD2.
PDCD2 is the human homologue of the rat Rp8 gene, which was identified in a subtractive hybridization screen for mRNAs whose expression correlates with programmed cell death in thymocytes (Kawakami et al, 1995; Owens et al., 1991) . Other experiments, however, have failed to find a correlation between apoptosis and Rp8 expression, and Rp8 and PDCD2 appear to be ubiquitously expressed in rat and human tissues (D'Mello and Galli, 1993; Kawakami et al., 1995; Owens and Cohen, 1992; Vaux and Hacker, 1995) . The predicted open reading frame of the PDCD2 mRNA contains a putative zinc finger, which is homologous to the MYND domain of ETO/MTG8 (Lutterbach et al., 1998a; Owens et al., 1991) .
The MYND domain of ETO is required for the repression of transcription mediated by the t(8;21) translocation protein product AML/ETO in acute myeloid leukemia, and acts through recruitment of the N-CoR/mSin3A corepressor complexes (Gelmetti et al., 1998; Lutterbach et al., 1998a,b; Melnick et al., 2000; Wang et al., 1998) . Several proteins contain MYND domains, including MTG8-related 1 (MTGR1), nervy, deformed epidermal autoregulatory factor 1 (DEAF-1), nuclear DEAF-1 related protein (NUDR), and suppressin (Feinstein et al., 1995; Gross and McGinnis, 1996; Huggenvik et al., 1998; Kitabayashi et al., 1998; LeBoeuf et al., 1998) . Apart from this domain, these proteins are unrelated in sequence to ETO. However, NUDR has been shown to repress transcription, DEAF-1 regulates transcription, suppressin is a growth suppressor of unknown mechanism, and MTGR1, like ETO, has been shown to be involved in myeloid malignancies through translocations with chromosome 21 (LeBoeuf et al., 1998; Michelson et al., 1999; Morohoshi et al., 2000; Sugihara et al., 1998) .
Results
In order to investigate a possible role of the WYF domain of HCF-1, a yeast two-hybrid screen was performed using the carboxy-terminal amino acids 1793 through 2035 as bait. An alignment of this region of the human HCF-1, human HCF-2, and C. elegans HCF (ceHCF) is shown in Figure 1 . HCF-1 amino acids 1793 to 2035 were fused to the GAL4 DNAbinding domain (HCF-1 bait ). A human fetal brain cDNA library fused to the GAL4 activation domain was used as the second component of the yeast twohybrid screen. Seven clones were found to interact with HCF-1 bait , but not with two unrelated protein controls, p53 and MBD3 (a methylated-DNA binding protein; these controls are used throughout the yeast twohybrid assays described herein). As a secondary screen for HCF-specificity, each positive clone was tested for interaction with the equivalent region of ceHCF, ceHCF 550 -782 (data not shown). Three clones also interacted with ceHCF and were chosen for further study. Upon sequencing, the three clones were found to be identical, containing the full-length cDNA encoding PDCD2 and about 60 nucleotides of 5' untranslated sequence. To show that the PDCD2 protein was Figure 1 The WYF domain of human HCF-1 is conserved in HCF-2 and C. elegans HCF. The domain structure of human HCF-1, HCF-2 and C. elegans HCF (ceHCF) is shown, along with positions of an alignment of the WYF domains, identical and conservative amino acid substitutions are highlighted. The WYF domain from HCF-1 was used as the bait in a two-hybrid screen responsible for the interaction with HCF-1 bait , the PDCD2 open reading frame was fused directly to the GAL4 activation domain (AD-PDCD2) and assayed for interaction. As shown in Figure 2a , AD-PDCD2 interacts specifically with HCF-1 bait .
The protein sequence of PDCD2 is highly conserved between human, C. elegans, and Drosophila melanogaster (Figure 2b) . Furthermore, PDCD2 contains a region that is homologous to the MYND domain of ETO/MTG8, and to similar domains in other eukaryotic proteins. An alignment of the putative MYND domain of PDCD2 with homologous domains in ETO and other proteins is shown in Figure 2c .
To map the interaction between PDCD2 and HCF-1 bait , truncations of PDCD2 were fused to the GAL4 activation domain and tested for interaction with HCF-1 bait in yeast (Figure 3) . None of the truncations tested were found to interact with an unrelated protein control. PDCD2 175 -300 interacted with HCF-1 bait (Figure 3d The smallest fragment of PDCD2 tested that interacted with HCF-1 bait , PDCD2 150 -200 , was also assayed for interaction with HCF-2 and ceHCF to determine if this region is able to bind the different HCF species (Figure 4 ). PDCD2 150 -200 specifically interacted with all HCF species tested, suggesting that this function of PDCD2 is conserved from humans through C. elegans.
Next, the region of HCF-1 required for interaction with PDCD2 was mapped using a GST pull-down assay. PDCD2 100 -344 interacted with HCF-1 by yeast Polyclonal antisera (2186) were raised in rabbits to a synthetic peptide consisting of the carboxy-terminal amino acid sequence of PDCD2. Antiserum 2186 was used to detect PDCD2 in a number of cell lines and revealed a single band at the expected size of 37 kD (Figure 6a ). To determine if PDCD2 and HCF-1 interact in cell extracts, endogenous protein immunoprecipitations were performed with PDCD2 antiserum 2186 (Figure 6b ). Extracts of COS-1 cells were incubated with 2186 antiserum covalently coupled to protein A sepharose, or with unmodified protein A sepharose beads. Immunoprecipitates were probed with antisera to the carboxyl terminus of recombinant HCF-1, arHCF serum (see Scarr et al., 2000) . PDCD2 antiserum coimmunoprecipitated bands which comigrated with intact (arrow) and fragments of HCF-1 (230 kd; the more rapidly migrating set of bands), whereas protein A sepharose alone did not, indicating that PDCD2 and HCF-1 are capable of associating in COS-1 cell extracts (Figure 6b, lanes 1 and 2) .
PDCD2 shows a short region of homology with a number of proteins, many of which have been identified as transcription regulators (see Figure 2c ). This region has been identified as an MYND domain in ETO (MTG8), and has been shown to interact with N-CoR/Sin3A complexes in mammalian cells (Gelmetti et al., 1998; Lutterbach et al., 1998a,b; Melnick et al., 2000; Wang et al., 1998) . To determine if PDCD2 also associates with N-CoR, PDCD2 antiserum and protein A sepharose immunoprecipitates were probed with aNCoR antiserum (Figure 6c) . A band that migrated at the expected molecular weight (270 kd) of intact NCoR was specifically immunoprecipitated by 2186 antiserum, but not with protein A sepharose alone, indicating that PDCD2 associates with N-CoR in COS-1 cell extracts.
An assay for HCF-1 function in vivo is complementation of the tsBN67 cell line. This cell line has a mutation in the X-linked HCF-1 gene and arrests its growth at the nonpermissive temperature, 39.58C. When HCF-1 is ectopically expressed in these cells, they are able to cycle at the nonpermissive temperature . To determine if PDCD2 is involved in HCF-1 directed cell-cycle regulation in the tsBN67 cell line, the effect of cotransfection with PDCD2 on complementation was investigated (Figure 7a ). tsBN67 cells were transfected with the pCLNeo vector alone (left panel), pCLNeo vector and pCGN-HCF (middle panel), or pCLNeo, pCGN-HCF, and pRC-FLAG-PDCD2 (right panel). Transfected cells were selected with G418 and grown at 39.58C for 2 weeks. In each case, the amount of transfected Neo r gene was the same. Transfection with a functional HCF-1 gene, pCGN-HCF-1, gave an increase in colony formation at the nonpermissive temperature (second panel, Figure   Figure 4 7a), indicating a rescue of the temperature-sensitive arrest. Interestingly, cotransfection of HCF-1 (pCGN-HCF) and PDCD2 (pRC-FLAG-PDCD2) greatly decreased colony formation (third panel, Figure 7a ), suggesting that overexpression of PDCD2 can negatively regulate or interfere with HCF-1 function. PDCD2 is not inducing cell death in these experiments as approximately the same number of neo-resistant small colonies were observed in the presence and absence of PDCD2 overexpression.
Fragments of PDCD2 and HCF-1 which are sufficient for interactions of these two proteins were used in complementation assays to determine whether they would act as dominant negatives by blocking the association of PDCD2 and HCF-1 (Figure 7b ). tsBN67 cells were transfected with pCLNeo (left panel); 
Discussion
We have identified a new protein interaction between HCF-1 and a cellular factor, PDCD2. This interaction maps to the region between amino acids 1910 and 2005, within the WYF domain in the carboxy-terminus of HCF-1. This domain is conserved between the human proteins HCF-1 and HCF-2, and the C. elegans homologue, ceHCF (Johnson et al., 1999; Liu et al., 1999) . The region of PDCD2 required for interaction with HCF-1 maps to amino acids 175 to 200 of the protein, and a fragment encoding amino acids 150 to 200 is able to interact with HCF-1, HCF-2, and ceHCF in a yeast two-hybrid assay. We demonstrate that HCF-1 can be immunoprecipitated by PDCD2 antiserum, indicating that the two proteins interact in mammalian cell extracts.
PDCD2 is the human homologue of the rat Rp8 gene (Kawakami et al., 1995; Owens et al., 1991) . Neither the Rp8 nor PDCD2 proteins have been previously characterized, apart from the identification of a putative zinc finger. A search of the Genbank database revealed a short region of homology between PDCD2 and a number of other eukaryotic proteins, including ETO (MTG8), MTGR1, nervy, DEAF-1, NUDR, and suppressin (Feinstein et al., 1995; Gross and McGinnis, 1996; Huggenvik et al., 1998; Kitabayashi et al., 1998; LeBoeuf et al., 1998) . This domain has been identified as an MYND domain in ETO, and is required for association of ETO with N-CoR/ mSin3A complexes (Gelmetti et al., 1998; Lutterbach et al., 1998a,b; Melnick et al., 2000; Wang et al., 1998) . Outside of this region, PDCD2 bears no resemblance to other known proteins.
Anti-PDCD2 serum coimmunoprecipitates N-CoR, suggesting that PDCD2 is also able to associate with N-CoR/mSin3A complexes, presumably through the MYND domain. N-CoR/mSin3A complexes repress transcription by recruiting histone deacetylase, which in turn modifies the chromatin (Laherty et al., 1997; Nagy et al., 1997) . The potential association of NCoR/mSin3A complexes with HCF-1 through their mutual interactions with PDCD2 conflicts with the previously described role of HCF-1 as a coactivator, at least in the context of the GABP transcription factor (Vogel and Kristie, 2000b) . We cannot rule out the possibility that PDCD2/N-CoR and PDCD2/HCF-1 associations are incompatible, although the regions of PDCD2 that interact with HCF-1 and are thought to interact with N-CoR do not overlap.
Ectopic expression of PDCD2 represses complementation of the tsBN67 cell line by HCF-1. tsBN67 cells, which have a mutation in their only copy of the HCF-1 gene, arrest in the Go phase at the nonpermission temperature, suggesting that HCF-1 is required for cell-cycle progression. Overexpression of PDCD2 reduces complementation of tsBN67 cells by HCF-1, possibly through repression of HCF-1-directed transcription of genes required to drive the cell cycle. Expression of minimal polypeptides of either HCF-1 or PDCD2, which should block the association of HCF-1 and PDCD-2, had the opposite effect: they stimulate the ability of transfected HCF-1 to complement the defect in tsBN67 cells. Furthermore, we, and others, have noted that the aminoterminus of HCF-1 alone complements the temperature-sensitive defect more efficiently than full-length HCF-1 . This suggests that deleting the C-terminus of the HCF-1 region may allow for greater upregulation of growth-progression genes by the N-terminus of the protein, possibly by the absence of colocalization of PDCD2 and an associated suppressive activity.
HCF-1 acts as a coactivator for GABP, an ets domain transcription factor that activates a variety of cellular genes including IL-2, RB, and cytochrome oxidase (Hoffmeyer et al., 1998; Sowa et al., 1997; Virbasius et al., 1993; Vogel and Kristie, 2000b) . HCF-1 may in fact function as a transcription regulator, alternately activating and repressing gene expression directed by its DNA-binding targets, GABP, Luman, and Zhangfei, and possibly others. Luman, a basic leucine zipper protein that binds to HCF-1, is sequestered in the cytoplasm by the Hepatitis C virus (HCV) core protein in infected cells (Jin et al., 2000; Lu et al., 1997) . Transfection of HCV core protein into NIH3T3 cells results in morphological transformation and anchorage-independent growth, and the authors propose that Luman therefore directs the transcription of growth arrest genes. HCF-1, which interacts with Luman, may recruit N-CoR/mSin3A complexes, through PDCD2, insuring that Luman targeted genes are repressed in cycling cells. Loss of the interaction between Luman and HCF-1 in tsBN67 cells may therefore result in the inappropriate activation of growth arrest genes and the arrest of cell division. In this scenario, at some point in the chain of interactions of Luman-HCF-1-PDCD2-N-CoR/m Sin3A cell cycle depended regulation is conjectured to interfere to appropriately control cell division. In wild type cells, the activities of HCF could be regulated by a number of different mechanisms. For example, the carboxyterminus of HCF-1 interacts with protein phosphate 1 (PP1), which could modulate phosphorylation state of proteins. Similarly, autoproteolysis of HCF-1 may affect the association of one or more members of a regulatory complex.
HCF-1 is involved, along with VP16 and Oct-1, in the C1 complex, which activates transcription of the immediate early genes of HSV. Evidence suggests that the PP1 phosphatase is excluded from this complex, and it is possible that PDCD2 suffers the same exclusionary fate. Consistent with this possibility, we have not observed repression of VP16 mediated transcription by overexpression of PDCD2 (data not shown).
Because HCF-1 may be both a coactivator and a cosuppressor of transcription, it is difficult to interpret the effects of overexpression of fragments of PDCD2 and HCF-1 that block the interaction between the full-length proteins on the complementation of tsBN67 cells by HCF-1. Overexpression of PDCD2, which greatly reduces complementation by HCF-1 in tsBN67 cells, may further suppress Luman-activated growth arrest, but may also cause inappropriate suppression of other genes for which HCF-1 is an activator. The overexpression of either of the HCF-1 or PDCD2 fragments in the complementation assay results in a greater number of colonies than with HCF-1 alone, suggesting that blocking PDCD2 association with HCF-1 increases cell growth. These dominant-negative peptides may cause the upregulation of both growth suppression and growth progression genes, and because the specific target genes involved are unknown, the outcome cannot be predicted. Furthermore, HCF-1 may not be the only protein with which PDCD2 associates, so a number of pathways may be altered by the overexpression of PDCD2 and the dominant-negative polypeptides. It should be noted that PDCD2 maps to chromosomal band 6q27, a region in which translocations also occur in leukemias and lymphomas, and which contains a putative tumor suppressor gene (Amiel et al, 1999; Hauptschein et al., 2000; Kawakami et al., 1995; Stilgenbauer et al., 1999) .
Materials and methods

Yeast two-hybrid screen
Amino acids 1793 to 2035 of HCF-1 were cloned behind the GAL4 DNA-binding domain in vector pAS2.1 (Clontech), creating an amino-terminal GAL4 DBD fusion (HCF-1 bait ). HCF-1 bait was transformed into yeast strain PJ69.2A and mated to yeast strain Y187 carrying a human fetal brain cDNA library fused to the GAL4 activation domain (GAL4-AD, Clontech). Diploids were plated and clones were selected as per the Clontech Matchmaker protocol. GAL4-AD fusions isolated from His+/Leu+/Trp+/b-gal+diploids were tested for interaction with HCF-1 bait , GAL4-p53, and GAL4-MBD3. Clones that specifically interacted with HCF-1 bait were then tested for interaction with the C. elegans HCF WYF domain, ceHCF 550 -782 . Positive clones were sequenced to determine the identity of the insert.
PDCD2 truncation analysis
Truncated fragments of PDCD2 were isolated by PCR and cloned into vector pACT2 (Clontech) to make GAL4-AD fusions. Fusions were transformed into yeast strain PJ69.2A carrying either HCF-1 bait or a control protein (GAL4-p53 or GAL4-MBD3). Transformants were plated on SD-Agar-His/-Leu/-Trp, grown for several days at 308C, and scored for protein-protein interaction. The smallest truncated fragment (PDCD2 150 -200 ) was then tested for interaction with ceHCF 550 -782 ) and HCF-2 550 -782 .
Pull-down assays
The cDNA for amino acids 100 -344 or 200 -344 of PDCD2 was cloned into vector pGEX-5673 (Pharmacia) to make amino-terminal GST-fusions (GST-PDCD2 100 -344 and GST-PDCD2 200 -344 ). GST fusions were expressed in bacteria and batch purified using glutathione-sepharose. Purified proteins were confirmed to be the correct size and quantitated after separation on an SDS -PAGE gel by visualization with Coommassie blue. Truncations of HCF-1 were made by PCR and fused to an amino-terminal FLAG tag and nuclear localization signal (FLAG-NLS) in vector pcDNA3 (Invitrogen). Five mg of each truncation was transfected into one 10 cm plate of COS-1 cells at 30% confluency using Fugene (Boehringer Mannheim).
Antibodies
Antibodies were raised to a synthetic peptide containing the carboxy-terminal sequence of PDCD2 (YTEEFVWKQDV-TDTP), in New Zealand white rabbits by Covance, Inc.
Coimmunoprecipitations
Untransfected COS-1 cells were harvested by scraping into phosphate-buffered saline (PBS) and pelleted at 10 000 g for 30 s. The cell pellet was resuspended in 5 cell pellet volumes of IP extraction buffer (1% NP-40, 150 mM NaCl, 50 mM Tris pH 8.0, 1 mM CaCl 2 , 0.5 mM EDTA, 0.5 mM PMSF) and incubated on ice for 30 min. Cell debris was removed by centrifugation at 10 g for 1 min. 2186 antiserum was covalently conjugated to protein A sepharose per the manufacturer's instructions (Protein A Ig Orientation Kit, Pierce). 80 ml each of a 50% slurry of 2186-protein A sepharose and unconjugated protein A sepharose were washed in excess IP buffer (150 mM NaCl, 50 mM Tris pH 8.0, 1 mM CaCl 2 , 0.5 mM EDTA, 0.5 mM PMSF) and pelleted by centrifugation at *1000 g. The supernatants were removed and IP buffer was added to a total volume of 540 ml each. 60 ml of COS-1 cell extract was added to each and allowed to bind for 3 h at 48C with rotation. Beads were pelleted and washed twice with 300 ml of IP buffer plus 0.1% NP-40. 40 ml of 26SDS loading buffer was added to each. 20 ml was loaded per lane on a 4 -20% SDS polyacrylamide gel. HCF-1 protein was detected using a 1 : 1000 dilution of arHCF polyclonal rabbit antiserum (the arHCF-1 antiserum was a generous gift from W Herr and reacts with the carboxyl terminus of HCF-1 as shown in Scarr et al., 2000) , followed by a 1 : 5000 dilution of horseradish peroxidase (HRP)-conjugated donkey anti-rabbit serum (Amersham) . NCoR protein was detected using a 1 : 125 dilution of anti-NCoR polyclonal rabbit antiserum (Santa Cruz), followed by a 1 : 5000 dilution of HRP-conjugated donkey anti-rabbit serum (Amersham). Western blots were developed using Renaissance enhanced chemiluminescent substrate (NEN).
Expression constructs
Full length PDCD2 was cloned into pRC/CMV (Invitrogen) with an amino-terminally fused FLAG tag to make pRC-FLAG-PDCD2. Truncations of PDCD2 were amplified by PCR and cloned into pcDNA4 (Life Technologies) to make pcDNA4-PDCD2. Truncations of HCF-1 were amplified by PCR and cloned into vector pcDNA3 (Life Technologies) with an amino-terminally fused FLAG tag to make pcDNA3-FLAG-HCF-1.
Complementation assays
tsBN67 cells were plated in DMEM supplemented with 10% IFS in 6-well dishes and grown at 33.58C. Cells were transfected with 2.2 mg pCLNeo (Promega), 2 mg pCLNeo and 0.2 mg pCGN-HCF (gift of W Herr), or 1 mg pCLNeo and 0.2 mg pCGN-HCF and either 1 mg of pRC-FLAG-PDCD2, 1 mg pcDNA4-PDCD2 150 -200 , or 1 mg pcDNA3-FLAG-HCF-1 1888 -2035 using Fugene (Boehringer Mannheim). Forty-eight hours later, the cells were split 1 to 4 into 10 cm dishes, and selected with 1 mg/ml G418 and shifted to 39.58C. Cultures were split 1 to 20, 4 to 5 days later and plated in 10 cm dishes under the same selection. Ten days later, cells were fixed and stained with crystal violet solution (0.2% crystal violet in 10% PBS-buffered formalin) for 20 min, followed by copious washing with distilled water.
